A bipartisan group of lawmakers introduced a bill in the U.S. House of Representatives on Monday that would give the Food and Drug Administration (FDA) flexibility to allow hemp-derived cannabidiol (CBD) to be sold as a dietary supplement.
House Agriculture Committee Chairman Collin Peterson, D-Minn., filed the bill amending the Federal Food, Drug, and Cosmetic Act (FD&C), and it is co-sponsored by James Comer, R-Ky.; Chellie Pingree, D-Maine; and Thomas Massie, R-Ky.
Peterson said in a press release, “This bill will allow FDA to regulate CBD that comes from hemp as a dietary supplement, providing a pathway forward for hemp-derived products.” The bill would also require the Department of Agriculture to produce a report on the regulatory and market barriers faced by hemp farmers.
To read more, click on https://www.fool.com/investing/2020/01/15/new-bipartisan-bill-could-clear-the-way-for-cbd-su.aspx
To read the bill, click on https://hempsupporter.com/assets/uploads/HR5587_Peterson.pdf